ReleaseWire

Global Markets Direct's, 'Epilepsy - Pipeline Review, H1 2014', provides an overview of the Epilepsy's therapeutic pipeline.

Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. GlobalData expects that the growing popularity of pediatric combination vaccines, along with the arrival of vaccines that achieve higher seroconversion rates in high-risk adults, will serve to stimulate growth in the marketplace over the forecast period. Country-specific immunization recommendations and policy implementation will be an essential metric for determining future vaccine uptake in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan) and Canada.

Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. GlobalData expects that the growing popularity of pediatric combination vaccines, along with the arrival of vaccines that achieve higher seroconversion rates in high-risk adults, will serve to stimulate growth in the marketplace over the forecast period. Country-specific immunization recommendations and policy implementation will be an essential metric for determining future vaccine uptake in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan) and Canada.

Global Markets Direct's, 'Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2014', provides an overview of the Vancomycin-Resistant Enterococcus Faecium Infections's therapeutic pipeline.

Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, Essential Oils), Livestock (Pork/Swine, Poultry, Ruminant, Aquaculture, Others) & by Geography (North America, Europe, Asia-Pacific, Rest of the World) - Global Trends & Forecasts to 2019

Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. GlobalData expects that the growing popularity of pediatric combination vaccines, along with the arrival of vaccines that achieve higher seroconversion rates in high-risk adults, will serve to stimulate growth in the marketplace over the forecast period. Country-specific immunization recommendations and policy implementation will be an essential metric for determining future vaccine uptake in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan) and Canada.

Global Markets Direct's, 'Dyslipidemia - Pipeline Review, H1 2014', provides an overview of the Dyslipidemia's therapeutic pipeline.

Global Markets Direct's, 'Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2014', provides an overview of the Uterine Leiomyoma (Uterine Fibroids)'s therapeutic pipeline.

Description Digestive system disease is one of the most frequently occurring diseases. According to statistics from WHO, there are at least 250 million people worldwide suffering from digestive system diseases, especially canker.

GlobalData's clinical trial report, "Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Non-Small Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Small Cell Lung Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Non-Small Cell Lung Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014', provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease)'s therapeutic pipeline.

Global Markets Direct's, 'Myocardial Infarction - Pipeline Review, H1 2014', provides an overview of the Myocardial Infarction's therapeutic pipeline.

GlobalData's clinical trial report, "Colon Cancer Global Clinical Trials Review, H1, 2014" provides data on the Colon Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Colon Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Colon Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Substance (Drug) Abuse - Pipeline Review, H1 2014', provides an overview of the Substance (Drug) Abuse's therapeutic pipeline.

Global Markets Direct's, 'Neuropathic Pain - Pipeline Review, H1 2014', provides an overview of the Neuropathic Pain's therapeutic pipeline.

The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the clinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.

The modern world isn’t a forgiving environment for those suffering from arthritis pain. Hectic schedules and work responsibilities have led many to seek ways to incorporate natural supplements into their daily routines. VitaBreeze is one of the companies leading the way to relief from arthritis pain with its Glucosamine, Chondroitin, MSM & Turmeric supplement.

Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. GlobalData expects that the growing popularity of pediatric combination vaccines, along with the arrival of vaccines that achieve higher seroconversion rates in high-risk adults, will serve to stimulate growth in the marketplace over the forecast period. Country-specific immunization recommendations and policy implementation will be an essential metric for determining future vaccine uptake in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan) and Canada.

Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. GlobalData expects that the growing popularity of pediatric combination vaccines, along with the arrival of vaccines that achieve higher seroconversion rates in high-risk adults, will serve to stimulate growth in the marketplace over the forecast period. Country-specific immunization recommendations and policy implementation will be an essential metric for determining future vaccine uptake in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan) and Canada.

Global Markets Direct's, 'Cervical Cancer - Pipeline Review, H1 2014', provides an overview of the Cervical Cancer's therapeutic pipeline.

Global Markets Direct's, 'Tuberculosis - Pipeline Review, H1 2014', provides an overview of the Tuberculosis's therapeutic pipeline.

Global Markets Direct's, 'Malignant Pleural Mesothelioma - Pipeline Review, H1 2014', provides an overview of the Malignant Pleural Mesothelioma's therapeutic pipeline.

Global Markets Direct's, 'Peritoneal Cancer - Pipeline Review, H1 2014', provides an overview of the Peritoneal Cancer's therapeutic pipeline.

Global Markets Direct's, 'Dompe Farmaceutici S.p.A. - Product Pipeline Review - 2014', provides an overview of the Dompe Farmaceutici S.p.A.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Duchenne Muscular Dystrophy - Pipeline Review, H1 2014', provides an overview of the Duchenne Muscular Dystrophy's therapeutic pipeline.